Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 4/12/2019
SIETES contiene 92848 citas

 1 a 20 de 48 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita originalTiene citas relacionadas Cita con resumen
Newman CB, Preiss D, Tobert JA, Jacobson TA, Page II RL, Goldstein LB, Chin C, Tannock LR, Miller M, Raghuveer G, Duell PB, Brinton EA, Pollak A, Braun LT, Welty FK. Statin safety and associated adverse events: a scientific statement from the American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology 2019;39:enero. [Ref.ID 103011]
2.Enlace a cita original Cita con resumen
Daneman N, Lu H, Redelmeier DA. Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort stuy. BMJ Open 2015;5:e010077. [Ref.ID 100135]
3. Cita con resumen
Stephenson AL, Wu W, Cortes D, Rochon PA. Tendon injury and fluoroquinolone use: a systematic review. Drug Saf 2013;36:709-21. [Ref.ID 96211]
4. Cita con resumen
Anónimo. Corticosteroids: musculoskeletal adverse events. New Zealand. WHO Drug Information 2013;27:20-1. [Ref.ID 95294]
5. Cita con resumen
Wise BL, Peloquin C, Choi H, Lane NE, Zhang Y. Impact of age, sex, obesity, and steroid use on quinolone-associated tendon disorders. Am J Med 2012;125:e23-28. [Ref.ID 93278]
6. Cita con resumen
Anónimo. Off-label use of ketorolac for athletic injuries. Med Lett Drugs Ther 2012;54:37. [Ref.ID 92970]
Lapi F, Tucori M, Motola D, Pugi A, Vietri M, Montanaro N, Vaccheri A, Leoni O, Cocci A, Leone R, Conforti A, Moretti U, Sessa E, Mazzaglia G, Mugelli A, Mazzei T, Vannacci A. Safety profile of the fluoroquinolones: analysis of adverse drug reactions in relation to prescription data using four regional pharmacovigilance databases in Italy. Drug Saf 2010;33:789-99. [Ref.ID 89273]
Liu HH. Safety profile of the fluoroquinolones: focus on levofloxacin. Drug Saf 2010;33:353-69. [Ref.ID 88432]
9. Cita con resumen
Anónimo. Tendinopathies dues aux statines. Prescrire 2010;30:29. [Ref.ID 87604]
de Vos RJ, Weir A, van Schie HTM, Bierma-Zeinstra SMA, Verhaar JAN, Weinans H, Tol JL. Platelet-rich plasma injection for chronic Achilles tendinopathy. A randomized controlled trial. JAMA 2010;303:144-9. [Ref.ID 87587]
11.Tiene citas relacionadas
Hurst LC, Smith T. Injectable collagenase Clostridium histolyticum for Dupuytren's contracture. The authors reply. N Engl J Med 2009;361:2579-80. [Ref.ID 87385]
12.Tiene citas relacionadas
Holzer LA, Holzer G. Injectable collagenase Clostridium histolyticum for Dupuytren's contracture. N Engl J Med 2009;361:2579. [Ref.ID 87384]
13.Tiene citas relacionadas Cita con resumen
Zhang P, Qin L. Injectable collagenase Clostridium histolyticum for Dupuytren's contracture. N Engl J Med 2009;361:2578-9. [Ref.ID 87383]
14. Cita con resumen
Hochberg AM, Pearson RK, O'Hara DJ, Reisinger SJ. Drug-versus-drug adverse event rate comparisons: a pilot study based on data from the US FDA Adverse Event Reporting System. Drug Saf 2009;32:137-46. [Ref.ID 85482]
15. Cita con resumen
Anónimo. Pûblic Citizen sues the FDA over tendon warning for fluoroquinolones. Scrip 2008;3325:13. [Ref.ID 81959]
Vyas H, Krishnaswamy G. Quinolone-associated rupture of the Achilles' tendon. N Engl J Med 2007;357:2067. [Ref.ID 81511]
17. Cita con resumen
Sode J, Obel N, Hallas J, Lassen A. Use of fluoroquinolone and riks of Achiles tendon rupture: a population-based cohort study. Eur J Clin Pharmacol 2007;63:499-503. [Ref.ID 80017]
Seeger JD, West WA, Fife D, Noel GJ, Johnson LN, Walker AM. Achilles tendon rupture and its association with fluoroquinolone antibiotics and other potential risk factors in a managed care population. Pharmacoepidemiol Drug Saf 2006;15:784-92. [Ref.ID 78690]
19. Cita con resumen
Corrao G, Zambon A, Bertù L, Mauri A, Paleari V, Rossi C, Venegoni M. Evidence of tendinitis provoked by fluoroquinolone treatment: a case-control study. Drug Saf 2006;29:889-96. [Ref.ID 78189]
20. Cita con resumen
van der Linden PD, Sturkenboom MCJM, Herings RMC, Leufkens HMG, Rowlands S, Stricker BHCH. Increased risk of Achilles tendon rupture with quinolone antibacterial use, especially in elderly patients taking oral corticosteroids. Arch Intern Med 2003;163:1801-7. [Ref.ID 67028]
Seleccionar todas
 1 a 20 de 48 siguiente >>